Clinical trial

Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

NCT05570409

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2023-03-28

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2023-03-28Date precision: day

Registry last updated2025-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Inflammatory Cardiomyopathyunresolved

Interventions

Mycophenolate MofetilDRUG · verified · RxNorm: mycophenolate mofetil

PrednisoloneDRUG · verified · RxNorm: prednisolone

Mycophenolate Mofetil PlaceboDRUG

Prednisolone PlaceboDRUG

Sponsors & collaborators

LMU Klinikumlead sponsor

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)collaborator

Technical University of Munichcollaborator

Charite University, Berlin, Germanycollaborator

University Hospital, Essencollaborator

University Hospital Erlangencollaborator

University Hospital Tuebingencollaborator

Mapped research locations

BerlinGermany1 HamburgGermany1 MünchenGermany1 EssenGermany1 HeidelbergGermany1 FrankfurtGermany1 Freiburg im BreisgauGermany1 LübeckGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05570409 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.